与众不同的AnastoClip VCS快速血管吻合系统

一种连结系统能够提供了快速而精确的血管吻合，可以替代传统的缝合方法。

该系统称作AnastoClip VCS（血管闭合系统）。以阻断方式放置钛夹子顺应血管吻合而无需穿透血管腔。这就允许血管吻合能够进行收缩与扩张以容纳脉冲血流。该系统适用于不同类型血管手术，最常用于血管入口处。

由于终末期肾病而接受血液透析的人数每年以6％的速度增长，仅仅在美国大约就有3000,000万人接受这种治疗。在这些患者中使用AnastoClip VCS，能够使最初的血管开放增加20％，同时减少手术时间、快速止血、无需使用昂贵的止血药物。这样就使得患者减少了外科手术以维持血管开放。

AnastoClip VCS是LeMaitre Vascular公司的产品，最近被U.S. Surgica公司所接受。 美国食品药品管理局业已批准并给予了CE标记。
 
Rapid Vascular Anastomosis System
 
An anastomosis system provides rapid and precise vascular anastomosis, replacing traditional sutures.

The system is called the AnastoClip VCS (vessel closure system). Titanium clips placed in an interrupted fashion facilitate a compliant anastomosis without penetrating the vessel lumen. This allows the anastomosis to contract and expand to accommodate pulsatile flow. The system can be used in a variety of vascular procedures, most commonly in vascular access.

The number of people receiving hemodialysis for end-stage renal disease is growing at 6% per year, with about 300,000 patients in the United States alone receiving this treatment. Use of the AnastoClip VCS for vascular access in these patients can result in a 20% increase in primary patency and reduced operating room time while providing immediate hemostasis, eliminating the need for expensive hemostatic agents. This benefits patients by reducing surgical revisions to maintain patency.

The AnastoClip VCS is the product of LeMaitre Vascular (Burlington MA, USA) and was recently acquired from U.S. Surgical (Norwalk, CT, USA). It has been cleared by the U.S. Food and Drug Administration (FDA) and has the CE Mark.